Michael Jarjour is president and CEO of ODH, Inc., a health technology company providing data aggregation and analytics solutions that enable the delivery of integrated health care. He oversees ODH’s overall operations and drives strategy for its flagship product, Mentrics, a clinically-focused technology platform that integrates social determinants, behavioral, physical, pharmacy and other health data into actionable insights for the health industry. With more than 20 years of experience in pharmaceutical and healthcare technology, Michael has a proven track record of growing businesses, maximizing revenues and building highly motivated, effective management teams on a global scale.
An entrepreneur, investor and advisor, Michael’s extensive experience leading healthcare and technology companies to significant growth makes him the ideal executive for ODH. His leadership, strategic and operational strengths for steering companies toward greater profitability have been recognized by his employers, peers and analysts.
Prior to leading ODH, Michael served as vice president, global commercialization and portfolio management at Otsuka Pharmaceutical and led the company’s global digital strategy. Before that, as president and CEO of Kinematik, he successfully grew the R&D software company. Throughout his career, he has held key leadership positions at Bristol-Myers, Pharmacia/Pfizer, Warner-Lambert/Pfizer and Wyeth with particular focus on executive management, marketing, operations, strategy and business development.
Michael’s expertise includes pharmaceutical and managed care sales, product marketing – from discovery to launch to generics - portfolio management, business development and therapeutic area leadership.
His strong entrepreneurial spirit stems from the first company he co-founded, Logonhealth Corporation, a provider of wireless handheld and web-based prescription solutions for physicians, pharmacists and patients, which was rated “best in class” by McKinsey & Co.
Michael is also committed to serving the tech and healthcare community. He is a venture partner and advisor at Mansa Capital, and previously served as CEO and board member of Pathonomics, a healthcare technology company developed at the University of Pennsylvania.
Michael earned his undergraduate degree in finance from Florida International University and his MBA from Rutgers University.